Abstract Details

Title Pooled Safety Analysis of Randomized, Prospective Studies on IncobotulinumtoxinA for the Treatment of Cervical Dystonia, Blepharospasm, and Upper Limb Spasticity

Topic Neuro-rehabilitation

Presentation(s) P5 - (-)

Poster/Presentation
Number 010

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
David M. Simpson, MD, FAAN (Icahn School of Medicine at Mount Sinai) PRESENTER	Dr. Simpson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Simpson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz.
Michael Hast	Michael Hast has received personal compensation for serving as an employee of Merz Therapeutics.
	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��